导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -10.06% | 826/1050 |
| 近一周 | -3.14% | 816/1104 |
| 近一月 | -4.07% | 505/1102 |
| 近一季 | -5.39% | 434/1092 |
| 近半年 | -6.15% | 658/1070 |
| 近一年 | -8.86% | 724/1018 |
| 近两年 | 64.67% | 398/926 |
| 近三年 | 34.45% | 358/834 |
| 成立以来 | 39.48% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.72% 994/1070 |
-1.70% 733/1101 |
- - |
- - |
| 2025 | 59.29% 113/1065 |
20.06% 26/1014 |
1.29% 570/1038 |
41.45% 168/1050 |
-7.39% 815/1065 |
| 2024 | -1.28% 617/1011 |
-7.69% 682/960 |
7.90% 36/983 |
3.07% 920/991 |
-3.83% 590/1011 |
| 2023 | -6.48% 237/952 |
3.72% 392/880 |
-2.06% 303/895 |
-6.11% 371/915 |
-1.95% 228/952 |
| 2022 | -29.99% 629/867 |
-28.68% 734/773 |
17.75% 57/806 |
-21.66% 775/845 |
6.41% 152/867 |
| 2021 | -11.48% 495/740 |
-9.71% 484/580 |
13.61% 271/659 |
-11.01% 533/704 |
-3.04% 544/740 |
| 2020 | 48.56% 242/554 |
-7.13% 341/419 |
20.64% 275/466 |
5.65% 353/517 |
25.50% 62/554 |
| 2019 | - - |
- - |
1.41% 213/1228 |
1.39% 295/390 |
4.25% 358/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 前海开源沪港深非周期股票C VS. 东吴新产业精选股票A(580008) |